
Cat. #162415
Monoclonal antibody anti-Acetylated (K12) Histone H4 (H4-4C10)
Cat. #: 162415
Target: acetylated (K12) Histone H4
Class: Monoclonal
Application: ELISA, WB, immunoprecipitation
Reactivity: Sequence conserved in wide range of species
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Monoclonal antibody anti-Acetylated (K12) Histone H4 (H4-4C10)
- Research fields: Epigenetics and Nuclear signalling
- Clone: H4-4C10
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Sequence conserved in wide range of species
- Host: Mouse
- Application: ELISA, WB, immunoprecipitation
- Description: Antibody to acetylated lysine 12 on histone H4, an epigenetic mark that can influence chromatin accessibility and gene expression in cancer.
- Immunogen: synthetic peptide: MSGRG(acetyl-K)GG(acetyl-K)GLG(acetyl-K)GGA(acetyl- K)RHRKVLR-(C) corresponding to aa 1 to 24 of human Histone H4
- Isotype: IgG1, k
- Additional notes: Avoid repeat freezing and thawing cycles. Does not contain any preservative.
Target Details
- Target: acetylated (K12) Histone H4
- Target background: Acetylation of lysine 12 on histone H4 is an epigenetic mark that can influence chromatin accessibility and gene expression in cancer.
Applications
- Application: ELISA, WB, immunoprecipitation
- Application notes: Available as crude ascites; Recommended dilutions: 1/500-1/5000
Handling
- Storage conditions: -20°C (up to 3 years)
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)



